Description
Pneumococcal 15‑valent Conjugate Vaccine is indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F, and 33F in individuals 6 weeks of age and older.
- Pneumococcal 15‑valent Conjugate Vaccine One Dose $1,800 (Including a doctor’s consultation)
Pneumococcal 15‑valent Conjugate Vaccine (with Dr consultation)
Clinical data supporting approval demonstrated non-inferior immune responses for all serotypes shared with PCV13 following a four-dose series and superior immune responses for important disease-causing shared serotype 3 and unique serotypes 22F and 33F compared to PCV13.
With this expanded indication, Pneumococcal 15‑valent Conjugate Vaccine is the first pneumococcal conjugate vaccine approved in almost a decade to help protect pediatric populations against invasive pneumococcal disease.
Who should get pneumococcal vaccines
- Children under 2 years old: The standard regimen includes a primary series of 3 doses at 2, 4 and 6 months and a booster dose at 12-15 months.
- Aged 2 or above : Single dose of pneumococcal conjugate vaccine is recommended.
Invasive pneumococcal disease (IPD) is an infection caused by the bacterium Streptococcus pneumoniae, or pneumococcus. While there are approximately 100 different types of S. pneumoniae, called serotypes, a smaller number of serotypes are responsible for IPD in children. Serotypes 3, 22F and 33F are three of the top five serotypes causing childhood cases of IPD. IPD can lead to hospitalization or death. Some examples of IPD are bacteremia (an infection in the blood) and meningitis (an infection of the coverings of the brain and spinal cord), which can also result in long-term neurological complications. Children under the age of 2 are particularly vulnerable to IPD.
Pneumococcal 15‑valent Conjugate Vaccine, Merck’s 15-valent pneumococcal conjugate vaccine, consists of purified capsular polysaccharides from S.pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F individually conjugated to CRM197 carrier protein. Pneumococcal 15‑valent Conjugate Vaccine is indicated for active immunization of individuals 6 weeks of age and older for the prevention of invasive disease caused by the S. pneumoniae serotypes contained in the vaccine. The FDA initially approved Pneumococcal 15‑valent Conjugate Vaccine in July 2021.
References
- Prescribing Information for Pneumococcal 15‑valent Conjugate Vaccine (Pneumococcal 15-valent Conjugate Vaccine) https://www.merck.com/product/usa/pi_circulars/v/vaxneuvance/vaxneuvance_pi.pdf
- Patient Information/Medication Guide for Pneumococcal 15‑valent Conjugate Vaccine at https://www.merck.com/product/usa/pi_circulars/v/vaxneuvance/vaxneuvance_ppi.pdf.
Instructions for use:
• The first dose must be given within 90 days after payment; All doses must be completed within 5-13 months after the first dose.
• Please show your confirmation information, order number, registered full name and phone number for verification.
Booking Process and Terms & Conditions：
- Customers will receive a confirmation email for successful payment after purchasing a vaccination from the Trinity Medical Centre online store. Trinity Medical Centre will contact customers during subsequent business hours to schedule the time and location for the vaccination appointment. Customers may also contact us for an appointment after order confirmation (Tel: 2192 7022 or Email: tmc@trinitymedical.com.hk).
- This package is exclusively available on Trinity Medical Centre’s online store and must be conducted at designated Trinity Medical Centres. It cannot be used with other promotions. The offer is non-transferable, non-refundable, and cannot be exchanged for full or partial cash value.
- Customers are required to make an appointment for and complete the first dose of the vaccine within 90 days from the date of purchase. If the vaccine requires only a single dose, it must be completed within this timeframe. All vaccinations (multi-dose) must be completed within 6 months from the date of the first dose; otherwise, they will become void.
- If this voucher or the confirmation email is lost or stolen, we will not accept any liability and will not provide any reissue in such case.
- All customers must present identification documents and the successful payment confirmation email during registration at the centre to be eligible for the service.
- If a parent or guardian purchases the service for a minor, the service user must accompany the parent or guardian to the centre for the examination.
- For any inquiries, please call 2192 7022 or email tmc@trinitymedical.com.hk.
- Trinity Medical Centre reserves the right to amend the terms and conditions without prior notice.
- In case of any disputes, Trinity Medical Centre reserves the right of final decision.
